$11.55
-$0.36 (-3.02%)
$11.51Day Range$11.82
Key Statistics
Market Cap
$9.62B
Shares Outstanding
833.0M
Primary Exchange
XNYS
Currency
USD
Type
ADRC
IPO Date
Apr 11, 2001
Round Lot
100
Locale
US
Trading Data
Day Open
$11.80
Day High
$11.82
Day Low
$11.51
Volume
4.23M
VWAP
$11.59
Prev Close
$11.91
Transactions
--
Acc. Volume
--
About Dr. Reddy's Laboratories Limited American Depositary Shares
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Identifiers
- CIK
- 0001135951
- Composite FIGI
- BBG000NJ96L6
- Share Class FIGI
- BBG001SHMCN3
- Ticker Root
- RDY
About Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) Stock
Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) closed the 2026-09-15 session at $11.55, down 3.02% versus the previous close (-0.36). The stock opened at $11.80 and traded between $11.51 and $11.82 during that session. Session trading volume was 4.2M shares. The volume-weighted average price (VWAP) is $11.59.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Dr. Reddy's Laboratories Limited American Depositary Shares has a market capitalization of $9.62 billion. RDY is listed on the XNYS exchange. The company employs approximately 27,527 people. The recorded listing date is 2001-04-11.
On this page you can find market RDY stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.